NCT00673972

Brief Summary

The purpose of this study is to compare postprandial distress syndrome and epigastric pain syndrome in demographics psychological features, infection of Helicobacter pylori, gastric emptying and therapeutic response to lansoprazole.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2008

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 5, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 7, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

March 10, 2010

Status Verified

March 1, 2010

Enrollment Period

1.6 years

First QC Date

May 5, 2008

Last Update Submit

March 8, 2010

Conditions

Keywords

Functional dyspepsiaGastric emptyingHelicobacter pyloriLansoprazoleEpigastric pain syndromePostprandial distress syndrome

Outcome Measures

Primary Outcomes (1)

  • Primary end point of the study is to compare the gastric emptying time in epigastric pain syndrome and that in postprandial distress syndrome

    After four-week treatment of lansoprazole

Secondary Outcomes (1)

  • Psychiatric distress, personality traits, infection of H. pylori and symptom improvement to lansoprazole

    after four-week treatment of lansoprazole

Study Arms (2)

EPS

ACTIVE COMPARATOR

Patients with functional dyspepsia will be classified into EPS or PDS two subgroups according to Rome III diagnostic criteria.

Radiation: gastric scintigraphy

PDS

ACTIVE COMPARATOR

Patients with functional dyspepsia will be classified into EPS or PDS two subgroups according to Rome III diagnostic criteria.

Radiation: gastric scintigraphy

Interventions

All tests start after overnight fast. Test meals consists of 120g scrambled egg, two slices of toasted bread, 30g of strawberry jam and 120ml of water. 12MBg (0.33mCi) of 99mTc sulfur colloid is mixed with egg thoroughly before the mixture cooked in a microwave oven for 2 minutes. All meals are prepared on the morning of examination and consumed within 20 minutes. Anterior and posterior images of the gastric region are taken within one minute after completion of test meals. Subsequent images are taken every 2 minutes in the first 60 minutes and at 120 minutes and 180 minutes. One-min images of gastric region at upright position are taken in the 140keV 99mTc peak with a 20% window.

Also known as: gastric emptying time
EPSPDS

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged greater than 20 years
  • fulfill Rome III diagnostic criteria

You may not qualify if:

  • children and teenagers aged less than 20 years
  • Organic lesions such as ulcers, tumors, bleeding, vasculopathy or esophagitis as demonstrated on upper endoscopy
  • concurrent illness with malignancy, diabetes mellitus, liver cirrhosis, renal failure or porphyria
  • diagnosis of organic disease for dyspeptic symptoms by treating physicians
  • history of abdominal surgery
  • concurrent user of aspirin and NSAID
  • history of allergy or severe side effects to lansoparzole
  • pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Study Officials

  • Ming-Shiang Wu, M.D.PHD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 5, 2008

First Posted

May 7, 2008

Study Start

April 1, 2008

Primary Completion

November 1, 2009

Study Completion

December 1, 2009

Last Updated

March 10, 2010

Record last verified: 2010-03

Locations